Despite decades of declining mortality rates, lung cancer remains the leading cause of
cancer death in the United States. This article examines lung cancer incidence, stage at …

Abstract On February 2, 2022, President Biden and First Lady Dr. Biden reignited the Cancer
Moonshot, setting a new goal to reduce age-standardized cancer mortality rates by at least …

Breast cancer survivors have an increased risk of developing second primary cancers, yet
risks by race and ethnicity have not been comprehensively described. We evaluated second …

Background Population-based survival studies of adult acute myeloid leukemia (AML) have
not simultaneously evaluated age at diagnosis, race and ethnicity, sex, calendar period or …

Access to and participation in cancer clinical trials determine whether such data are
applicable, feasible, and generalizable among populations. The lack of inclusion of low …

Cancer research has led to remarkable advances in our understanding of cancer biology
and strategies for prevention, screening and early detection, treatment, and survivorship …

Background People with HIV have higher risk of hepatocellular carcinoma than the general
population, partly because of higher prevalence of coinfection with hepatitis B virus (HBV) or …

Advances in cancer prevention, early detection and treatments have led to unprecedented
progress against cancer. However, these advances have not benefited everyone equally …

Background Native Hawaiians and other Pacific Islanders (NHPI) patients with head and
neck cancer are often aggregated with Asian individuals despite evidence of heterogeneous …

Polygenic scores (PGS) are promising in stratifying individuals based on the genetic
susceptibility to complex diseases or traits. However, the accuracy of PGS models, typically …